The Illness Narratives of Children and Young People With Spinal Muscular Atrophy: A Scoping Review
ABSTRACT Aim(s) This review seeks to explore the illness narratives of children and young people focusing on their healthcare trajectories; the right to health; and the kind of stories told about them. Design This scoping review adopts a narrative approach to analyse how the illness experience of Spinal Muscular Atrophy is represented in the literature,
Marcela González‐Agüero +6 more
wiley +1 more source
Electrophysiological Changes in Pediatric Spinal Muscular Atrophy: Results From an Observational Study. [PDF]
Sun R +8 more
europepmc +1 more source
Changes in the cortical GABAergic inhibitory system in a Spinal Muscular Atrophy mouse model. [PDF]
Menduti G +10 more
europepmc +1 more source
Vectors and Vector‐Borne Diseases: Biology, Epidemiology and Integrated Control Strategies
ABSTRACT Vector‐Borne Diseases (VBDs), transmitted by arthropods such as mosquitoes, ticks, fleas and sandflies, represent a significant threat to global health. These diseases can be caused by a variety of pathogens, including bacteria, viruses, protozoa, and helminths.
Roberta Rinaldi +4 more
wiley +1 more source
Clinicodemographic and Genetic Profile of Children with Spinal Muscular Atrophy in Kerala, India: A Single-Center Experience. [PDF]
Hafsa +6 more
europepmc +1 more source
Cyclin‐dependent kinase 13 is indispensable for normal mouse heart development
Congenital heart disease (CHD) is the most common defect in live births. The role of cyclin‐dependent kinase (CDK13) in cardiogenesis and CHD was studied using a transgenic mouse model (Cdk13tm1b) carrying deletion of exons 3 and 4, causing loss of function.
Qazi Waheed‐Ullah +8 more
wiley +1 more source
Assessment of safety and efficacy of risdiplam treatment in adults with spinal muscular atrophy. [PDF]
Jaworek A +12 more
europepmc +1 more source
Hip displacement management in spinal muscular atrophy in the era of disease modifying therapies: a Delphi consensus study in the UK. [PDF]
Vanegas MI +4 more
europepmc +1 more source
High-dose nusinersen for spinal muscular atrophy: a phase 3 randomized trial. [PDF]
Finkel RS +18 more
europepmc +1 more source
Effectiveness of Risdiplam Treatment in Adult Patients With Spinal Muscular Atrophy Type IIb-III. [PDF]
García Estévez DA.
europepmc +1 more source

